RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.

RadNet (NASDAQ:RDNT – Free Report) had its target price hoisted by Truist Financial from $80.00 to $94.00 in a research note ...

DeepHealth has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population ...

DeepHealth's AI-powered informatics portfolio features the newly introduced Diagnostic Suite™ and TechLive™1, integrated ...

Truist Financial analyst David S Macdonald reiterated a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $94.00. The company’s shares closed last Wednesday at $82.49.

Mutual of America Capital Management LLC cut its position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 10.4% ...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer ...

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables RadNet’s DeepHealth and GE HealthCare ...

Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of ...